Milestone Scientific Inc. (NYSEAMERICAN:MLSS) Short Interest Down 41.4% in August

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) saw a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 59,471 shares, a decrease of 41.4% from the August 15th total of 101,442 shares. Based on an average trading volume of 12,419 shares, the days-to-cover ratio is presently 4.8 days. Currently, 0.3% of the shares of the company are sold short.

Shares of MLSS stock traded down $0.01 on Friday, hitting $0.69. 4,727 shares of the stock were exchanged, compared to its average volume of 34,752. Milestone Scientific has a one year low of $0.62 and a one year high of $1.60.

Milestone Scientific (NYSEAMERICAN:MLSS) last issued its earnings results on Tuesday, August 14th. The medical instruments supplier reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.05) by $0.01. Milestone Scientific had a negative return on equity of 70.11% and a negative net margin of 49.67%. The business had revenue of $2.43 million during the quarter.

Milestone Scientific Company Profile

Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances.

See Also: NASDAQ Stock Market Explained

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply